Researchers who tested the vaccine in a combined Phase 1-2 trial — mostly meant to show safety — found either one or two doses of the vaccine generated both antibody and T-cell responses against the coronavirus. The trials were not…
The Oxford-AstraZeneca vaccine research project has today produced some encouraging results. But how does the potential vaccine stack up to it’s competitors? Subscribe: Read more here: ABC News provides around the clock coverage of news events as they break in…